Board of Directors

Harel Gadot

Harel Gadot, Chairman

Harel is a seasoned executive and entrepreneur in the healthcare space, where he has an extensive and proven track record of over 15 years of leadership in the corporate world as well as the start-up sector, including positions in the USA, Europe and Israel.

In 2010, Harel founded MEDX Ventures Group LLC, an investment and management firm with offices in the USA, Europe and Israel. Harel founded and serves as the CEO & Chairman of Microbot Medical Ltd., a promising early stage medical device company. In addition, Harel founded and serves as the Chairman of XACT Robotics™ Ltd., another transformational, early stage medical device company, where MEDX is the leading investor. Until 2013, Harel also served on the board of directors at ConTIPI Ltd., which was acquired in 2012 by a leading multinational corporation.

Until 2010, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, Harel was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc.), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, Harel led both companies to continuous growth in revenues and new product launches (both from internal R&D and M&A). Harel also held several management positions in marketing and sales at Johnson & Johnson Medical Israel.

Harel is a guest speaker for management and innovation courses at leading universities in the USA and Israel, including the Technion – Israel Institute of Technology. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).

 

Chen Levin

Chen Levin, Chief Executive Officer and Director

Chen is a seasoned leader in the healthcare space with vast experience in management and operational positions. Throughout her career, Chen contributed to and played an instrumental part of the Israeli biomed industry’s continuous growth.

Prior to leading XACT™, Chen served as the Executive Director of BioJerusalem, an initiative of the Prime Minister’s Office of the government of Israel to foster the biomed industry in Jerusalem, where she established numerous ventures and collaborations. Before BioJerusalem, Chen served as the CEO of Biomagnesium Systems Ltd., a medical device incubator company. Prior to this, Chen played a key role in the establishment of BioLineRx, Israel’s first Biomed Incubator (now a TASE publically traded company).

Chen started her career in policy research, helping shape important government biomed industry support schemes. Chen is a member of the founding and steering committee of Women in the Life Sciences Organization (WLSO) in Israel.

Chen holds a BA degree in International relations and an MBA in finance, both from the Hebrew University of Jerusalem.

 

Yoav Waizer

Yoav Waizer, Director

Yoav has more than 20 years of entrepreneurial experience working with private and publicly traded technology companies. As a partner and CFO at leading Israeli VC funds that include recently Medica Venture Partners and previously, Cedar Fund and Star Ventures, he has worked with start-up companies from their very early stages all the way to successful exits. His hands-on experience includes all aspects of finance and operations including tax planning and reporting, cash management, reporting to limited partnerships under US GAAP rules, investor relations, and has expertise in strategy, financial and legal due diligence, general and financial management, team-building, monitoring portfolio companies, raising capital and M&A.

Yoav holds a B.Sc. in Statistics and Accounting and an MBA with a specialization in Information Systems, both from Tel Aviv University.

 

Simon Sharon

Simon Sharon, Director and Chairman of the Scientific Advisory Board

Simon brings almost three decades of proven management, leadership and experience in operations, research and development, focusing mainly on medical devices.  Simon also serves as the Chairman of the Scientific Advisory Board of XACT Robotics.

Currently, Simon serves as the Chief Technology Officer at Microbot Medical, an early stage company developing a platform of micro-robots for various medical applications, for which, he was the COO prior to joining the incubator.

Prior to joining Microbot, Simon was the VP Research & Development at IceCure Medical Ltd., a TASE traded company developing a portfolio of cryogenic ablation systems. Before his experience with IceCure, Simon served as the CEO and VP Research & Development of Anorad Israel (a business unit of Rockwell Automation).

Prior to Anorad, Simon was the Research & Development Manager at Disc-O-Tech Medical Technologies Ltd., a successful orthopedic venture that was acquired by Kyphon (currently part of Medtronic), and before this as the Research & Development Manager at CI Systems.

Simon holds a BSc. In Mechanical Engineering from the Technion – Israel Institute of Technology, a MSc. in Mechanical Engineering from MIT where he specialized in motion control and robotics, and a MBA from the Kellogg-Recanati School of Management.

 

Yossi Bornstein

Yossi Bornstein, Director

Founder and President of Shizim Group, Israel’s leading biomed service group.

During the past 30 years, Mr. Bornstein has played key roles in the Israeli biomed industry.
Mr. Bornstein was the General Manager of Bristol-Myers Squibb (Israel), until 1992. He subsequently founded Pharmateam Ltd., an Israeli company that successfully specialized in representing International pharmaceutical companies such as 3M Health Care, G.D. Searle, Shire, Medimmune, United Therapeutics, Forest Laboratories, Goldshield and others. Pharmateam was sold in 2000, when Mr. Bornstein founded Shizim Ltd and through it all its subsidiaries.

Mr. Bornstein’s activity is not only recognized and appreciated in the business world, but also on a national level. He served as the Biotechnology Committee Chairman of USISTC (United States-Israel Science & Technology Commission), and also as a consultant for USISTC (United States-Israel Science & Technology Foundation). Through these organizations Mr. Bornstein has initiated, founded and led a number of major national level projects for the Israeli life-science industry and for the State of Israel. Amongst these: ILSI (Israel Life Science Industry Organization) – the biggest organization in Israel for representing the mutual goals of the Israeli life science community [merged into IATI], and ITTN (Israel Technology Transfer Organization), which serves as the umbrella organization for Israel’s academic Technology Transfer Offices, holding all innovative technologies from the entire Israeli academia.

Mr. Bornstein is a Committee Member at The Life Science Forum of IPCC – the Israeli-Palestinian Chamber of Commerce, and has also served as a member of the Advisory Board – Life Science Industry, The Israel Export & International Cooperation Institute.

 

Need more info?
Send us a message
© XACT Robotics™ 2019. All Rights Reserved. | Website by Volle'